NCT06732973View on ClinicalTrials.gov

A Bioequivalence Study of JS005 Pre-filled Syringe and JS005 Auto-injector

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

June 6, 2025

Study Completion Date

December 30, 2025

Conditions
Health Volunteer
Interventions
DRUG

JS005

JS005：The drug was administered by a single subcutaneous injection

Trial Locations (1)

450015

Zhengzhou Sixth People's Hospital, Zhengzhou

All Listed Sponsors
collaborator

Sponsor GmbH

OTHER

lead

Shanghai Junshi Bioscience Co., Ltd.

OTHER